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Abstract
Western-style diets (WD) high in fat and scarce in fiber and
vitamin D increase risks of colorectal cancer. Here, we performed a
long-term diet study in mice to follow tumorigenesis and char-
acterize structural and metabolic changes in colon mucosa asso-
ciated with WD and predisposition to colorectal cancer. WD
increased colon tumor numbers, and mucosa proteomic analysis
indicated severe deregulation of intracellular bile acid (BA)
homeostasis and activation of cell proliferation. WD also in-
creased crypt depth and colon cell proliferation. Despite increased
luminal BA, colonocytes from WD-fed mice exhibited decreased
expression of the BA transporters FABP6, OSTb, and ASBT and
decreased concentrations of secondary BA deoxycholic acid and
lithocholic acid, indicating reduced activity of the nuclear BA
receptor FXR. Overall, our results suggest that WD increases cancer
risk by FXR inactivation, leading to BA deregulation and increased
colon cell proliferation. Cancer Res; 77(12); 3352–63. 2017 AACR.
Introduction
Western-style diet (WD), rich in energy derived from saturated
fats of animal origin and scarce of fiber, vitamin D, calcium, and
folic acid, is recognized as one of the main risk factors for
colorectal cancer (1). Dietary fat has been implicated to increase
colorectal cancer risk, and associations have been found between
colorectal cancer incidence, saturated fat intake, and high con-
sumption of red and processed meat (2).
WD has been shown to promote important oncogenic pro-
cesses in colon tissue, aberrant apoptosis (3), proinflammatory
stimulus (4), and increased neoplastic growth (5). Our previ-
ous study highlighted that WD elevates fatty acid metabolism,
thus providing a source of reactive oxygen species (ROS) in
colon tissue (6). Consumption of high-fat diet like (HFD) WD
(20%–35% fat) results in significantly higher excretion of fecal
secondary bile acids (BA), mainly deoxycholic acid (DCA) and
lithocholic acid (LCA; ref. 7). BAs are known for emulsifying
effect on dietary fat; high secretion of DCA in colon lumen and
high BA concentrations in feces are indeed correlated with
increased incidence of colorectal cancer (8, 9). Furthermore,
high concentrations of luminal BAs are associated with
increased proliferation of colon epithelia (10) also indicating
pathogenicity. Overall, BA homeostasis seems to be a critical
tumor suppressor in colon (11, 12).
In the present study, we characterized functional changes
induced by Western-style diet in the colon mucosa of C57BL/6
mice. We complemented two high-throughput proteomics
methods, 2D difference gel electrophoresis (DIGE) and liquid
chromatography coupled mass spectrometry (LC-MS), both of
which provide insights into final cellular changes, unlikely to
be determined with other methods such as RNA sequencing.
Our proteomic analysis indicated aberrance in proliferation,
apoptosis, and BA metabolism in WD-fed mice. Concurrent
increase of proliferation and avoidance of apoptosis in normal
tissue is the most important oncogenic driver event when
considering hallmarks of cancer. Previous studies on WD
effects in mice have associated WD with hyperproliferation
due to reduced amount of dietary calcium (3) without addres-
sing known effects of BAs on proliferation. Previous studies
have linked colorectal cancer with high BA concentrations in
colon lumen and feces (13). Here, we studied colon crypt
depth, cell proliferation, and measured BA concentrations both
in colon lumen and in colon tissue, because only intracellular
BAs can directly affect nuclear receptors, gene expression, and
modulate cellular processes. Our comprehensive proteomic
study and targeted metabolomics coupled with histologic
analysis of colon tissue show that Western-style diet severely
activates cell proliferation and causes malabsorption of BAs in
colon epithelia, two phenomena associated with intestinal
tumorigenesis.
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Materials and Methods
Mice and diets
C57BL/6 mice were bred and treated according to the study
protocol approved by the National Animal Experiment Board in
Finland (ESLH-2008-06502/Ym-23).
Mice were randomly divided into two dietary groups at the age
of 6weeks and fed ad libitumwith control diet AIN-93G (American
Institute forNutrition, AIN; ref. 14) ormodifiedAINdiet tomimic
human Western style diet (Supplementary Table S1; Harlan
Teklad) previously described (6). Mice were kept in 12-hour
light/dark cycle with controlled temperature and humidity.
Sexes were equally represented in all experimental groups. We
sacrificedmice and collected specimens at 6 weeks, 12, 18, and 21
months of age. Size of each experimental group was between 8
and 12 animals. Experimental groups were 6-week, 12-month
AIN, 12-month WD, 18-month AIN, 18-month WD, 21-month
AIN, and 21-month WD. Histologic analyses of neoplasias/
tumors were carried out at The Finnish Centre for Laboratory
Animal Pathology, University of Helsinki, Finland. Detailed
description of mice used in each analysis and tumor information
is presented in Supplementary Table S2.
Specimens
A longitudinal piece of proximal colon mucosa was separated
from the smooth muscle layer under a dissecting microscope.
Samples for protein extractions were rinsed with tris-based buffer,
snap frozen, and stored at –80C. Samples for RNA extraction
were stored in RNAlater (Qiagen) at –80C until extraction.
Proximal colon tissue for BA analysis was stored in optimal
cutting temperature reagent at –80C.
Protein extraction
Colon mucosa was mechanically homogenized in (10–15 mL
lysis buffer/mg tissue) 2D Protein Extraction Buffer-VI (GE
Healthcare), pH 8.5 Tris (30 mmol/L; Sigma-Aldrich), Protease
Inhibitor Mix (1/100; GEHealthcare), and phosphatase inhibitor
cocktail 2 and 3 (Sigma-Aldrich). Homogenate was vigorously
shaken for 20 minutes at 4C followed by centrifugation at
15,000 g for 20 minutes. Supernatant was collected, snap frozen,
and stored at –80C. The concentration of total protein extracts
was measured with 2D Quant Kit (GE Healthcare).
2D-DIGE
We used 2D-DIGE to detect themost prominent changes in the
colon proteome expression, as described previously (6). The
reagents, instruments, and software were manufactured by GE
Healthcare if not stated otherwise. Samples were labeled with Cy3
and Cy5 (400 pmol of dye for 50 mg of sample) according to the
manufacturer's instructions. An internal standard was created
by pooling 25 mg of each protein sample and labeled with Cy2.
Equal amounts (50 mg) of internal standard (Cy2), Cy3, and
Cy5 labeled samples were actively introduced into immobilized
pH 3-11 nonlinear gradient (IPG) strips 24 cm long, using the
Ettan IPGphor II unit. After protein separation, according to their
isoelectric point, IPG strips were equilibrated with 1% dithio-
threitol (DTT) and 2.5% iodoacetamide. Finally, proteins were
separated in second dimension using precast large 12.5% SDS-
PAGE gels with constant power of 15Wper gel. Gels were scanned
with Typhoon Trio scanner and images acquired with excitation/
emission values 480/530 nm(Cy2), 520/590nm (Cy3), and 620/
680 nm (Cy5). Maximum intensities between different channels
differed less than 20% to 30%. DeCyder 2D 7.0 was used for
analysis of gel images.
Protein identification
In order to excise proteins from the 2D gels, we silver-stained
them with a PlusOne Silver staining kit (GE Healthcare). Pro-
teins were in-gel digested with trypsin (Trypsin gold; Promega)
as previously described (6). MALDI-MS and MS/MS analyses
were performed with UltrFlexTreme (Bruker Daltonics) using
SmartBeam II 355 nm laser. Calibration was externally per-
formed with peptide calibration standard (Bruker Daltonics).
MALDI-MS and MS/MS spectra were acquired by accumulation
of 5,000 to 7,000 or 10,000 to 20,000 shots, respectively. The
spectra were searched against UniProt/SwissProt database
[release of 2013_12, (541954 sequences; 192668437 residues),
taxon: Mus musculus (16649 sequences), www.uniprot.org]
using Mascot server (Matrix Science, www.matrixscience.com),
FlexAnalysis, and BioTools software (Bruker Daltonics). We used
the following search parameters: cleaving enzyme trypsin, one
missed cleavage allowed, peptide mass tolerance  0.1 Da for
MS searches, and fragment tolerance  0.5– 1.5 Da for
combined MS/MS searches. Variable and fixed modifications
were oxidized methionine and carbamidomethylation of cyste-
ine, respectively.
Sample preparation for LC-MS
Results obtained with 2D-DIGE were validated with nonlabel-
ing quantitative LC-MS. We combined equal amounts (10 mg) of
total protein extract of individual mouse belonging to each study
group and from created pools used 10 mg for digestion, using
modified filter-aided sample preparation protocol (15). Briefly,
the lysis buffer was exchanged by washing protein extracts several
times with 8 mol/L urea, 0.1 mol/L Tris, pH 8 (urea buffer, UB).
Reduction with 5 mmol/L DTT and alkylation with 50 mmol/L
iodoacetamide inUBwere followed by digestionwith 1:50 w/v of
Lysine-C endopeptidase (Wako) in 4 mol/L urea/0.1 mol/L Tris
pH 8 at room temperature overnight. The peptide digests were
collected by centrifugation, and trypsin solution was added in a
ratio of 1:50 w/v in 50 mmol/L ammonium bicarbonate. As
before, the digests were collected and combined. The peptide
samples were cleaned using C18 - reverse phase ZipTip (Milli-
pore), resuspended in 1% trifluoroacetic acid and ultrasonicated
in water bath for 1 minute.
LC-MS
We analyzed triplicates of each pooled sample. Digested pro-
teins (200ng)were injected for LC-MS analysis. The peptideswere
separated by nanoAcquity ultra pressure liquid chromatography
(UPLC) system (Waters) equipped with a trapping column 5 mm
Symmetry C18 180 mm  20 mm C18 reverse phase (Waters),
followed by an analytical 1.7mm,75mm 250mmBEH-130C18
reversed-phase column (Waters), in a single pump trapping
mode. The injected sample analytes were trapped at a flow rate
of 15 mL/min in 99.5% of solution A (0.1% formic acid). After
trapping, the peptides were separated with a linear gradient of 3%
to 35% of solution B (0.1% formic acid/acetonitrile), for 90
minutes at a flow rate 0.3 mL/min, and stable column temperature
of 35C. Every run was followed by two empty runs to wash out
any remaining peptides fromprevious runs. The sampleswere run
in data-independent analysis mode (MS), in a Synapt G2-S mass
spectrometer (Waters), by alternating between low collision
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energy (6V) and high collision energy ramp in the transfer
compartment (20 to 45 V) and using 1-second cycle time. The
separated peptides were detected online with mass spectrometer,
operated in positive, resolution mode in the range of m/z 50–
2,000 amu. Note that 150 fmol/mL of human [Glu1]-fibrinopep-
tide B (Sigma-Aldrich) in 50% acetonitrile/0.1% formic acid
solution at a flow rate of 0.3 mL/min was used for a lock mass
correction applied every 30 seconds.
Quantitation and database search
Relative quantification between pooled samples using precur-
sor ion intensities was performed with TransOmics Informatics
for Proteomics software (Nonlinear Dynamics, Waters) and Pro-
teinLynx Global Server (PLGS V3.0). We used following MS
parameters: low energy threshold of 135 counts, elevated energy
threshold of 30 counts, and intensity threshold of precursor/
fragment ion cluster 750 counts. Chromatograms were automat-
ically alignedby the TransOmics software using the default values.
Those that had alignment score 70% to the reference run were
selected for further analysis. Database searches were carried out
against UniProtKB-SwissProt (release 2014_04, taxon: Mus mus-
culus, 32538 entries) with Ion Accounting algorithm and using
automatic peptide and fragment tolerance, maximum protein
mass: 500 kDa, minimum fragment ions matches per protein
 7,minimum fragment ionsmatches per peptide 3,minimum
peptide matches per protein  1, primary digest reagent: trypsin,
missed cleavages allowed: 2, fixed modification: carbamido-
methylationC, variablemodifications: phosphorylationof serine,
tyrosine and threonine residues, oxidation of methionine, and
FDR < 4%. All identifications were subsequently refined to Mus
musculusonly identifiers and the protein lists simplifiedbyprotein
grouping. Protein quantitation was performed entirely on non-
conflicting protein identifications, using precursor ion intensity
data and standardized expression profiles.
Western blot analyses
Antibodies against FABP6 (1:1,000, 12579-RP09; Sino Biolog-
ical Inc.), ASBT (1:1,000, SLC10A2, CPBT-46249RM; Creative
Diagnostics), FXR (NR1H4, 1:500, A9033A; Novus Biologicals),
GAPDH (1:5,000, 14C10; Cell Signaling Technology), and
a-tubulin (1:20,000, clone DM1A; Sigma-Aldrich) were used in
Western blot analyses. Secondary antibodies were IRDye 800 CW
goat anti-rabbit IgG (926-32211) and IRDye 680 RD goat anti-
mouse IgG (926-68070; LI-COR). Briefly, 10 to 20 mg of sample
pools containing equal amounts of total protein extracts of each
mouse belonging to a respective group were separated on 4% to
20% gradient gels (Bio-Rad) and blotted on either Immobilon
PSQ (Millipore) or Trans-BlotTurbo (Bio-Rad). After antibody
incubation, the blots were scanned with Odyssey (LI-COR) and
quantifiedwith the Image Studio Lite (LI-COR) software. Loading
control, either a-tubulin or GAPDH, was used to normalize
protein abundance between different experimental groups.
Analysis of bile acids
BAs were extracted from proximal colon mucosa and fecal
content of colon lumen into ethanol as described previously
(16). Briefly, lyophilizated sampleswere pulverized in TissueLyser
(Qiagen). Nordeoxycholic acid (NDCA; Steraloids) was added
(1mg) to the samples prior the extraction as an internal standard to
monitor sample quality and quantify concentration of BA in the
samples. Freeze-dried proximal colon mucosa samples were
grinded in a ball mill and ultrasonicated (level 9, 120 W, USC-
600-THD, VWR) in ethanol for 1 hour, heated at 60C for
30 minutes, cooled to the room temperature, and boiled at 90C
for 3 minutes. Extracts were centrifuged at 1,600 g for 10 minutes
and supernatant was collected. Ethanol was added to precipitates
and vigorously mixed for 1 minute. Supernatant was collected
after centrifuging at 11,200 g for 1 minute. This was repeated
twice. Supernatants were pooled and ethanol evaporated in
vacuum concentrator. Extracts were dissolved in methanol and
purified withHLB cartridges (Waters). Liquid was evaporated and
BAs were finally reconstituted in 50 mL of methanol and analyzed
with UPLC-MS immediately. BAs from feces were extracted with
isopropanol without SPE extraction due to the fact that feces
contain mostly water and water-soluble inorganic salts, organic
material but also small amounts of bacterial matrix and proteins.
Liquid–liquid extraction was performed with isopropanol (IPA)
to extract BAs and to purify samples from water-soluble content
without time consuming SPE (17, 18). Samples were extracted
twice with 1 mL IPA, centrifuged, and evaporated to dryness.
Dry samples were reconstituted in 200 mL of acetonitrile and
analyzed with UPLC-MS immediately.
Q-TOF-MS detection of BAs
Extracted BAs were separated on Acquity UPLC BEH C18
column (1.7 mm, 50  2.1 mm, Waters) in þ40C attached to
Waters Acquity UPLC system (Waters). The mobile phase con-
sisted of (A) H2O and (B) acetonitrile (Chromasolv grade;
Sigma-Aldrich) both containing 10 mmol/L ammonium ace-
tate (Fluka/Sigma-Aldrich). A linear gradient started at 95% of
A, decreased to 60% in 10 minutes, then to 20% in 24 minutes,
then back to 95% in 24.1 minutes, and left to equilibrate for
1 minute. The injection volume was 3 mL, and flow rate of the
mobile phase was 0.6 mL/min. UPLC system was interfaced
with Waters Synapt G2 HDMS mass spectrometer (Waters).
Ionization was performed using an electrospray ionization
(ESI) source. Samples were analyzed in negative sensitivity ion
mode. Mass range was set from 50 to 600 amu. The ionization
parameters were optimized with the internal standard, NDCA.
BAs were identified by their m/z ratio and retention time and by
running BA standards deoxycholic acid, cholic acid, hyodeoxy-
cholic acid, chenodeoxycholic acid, ursodeoxycholic acid, LCA,
isoLCA, a-muricholic acid (aMCA), bMCA, wMCA, a-tauro-
muricholic acid (aTMCA), and wTMCA (Steraloids). The chro-
matograms and mass spectra were analyzed with Waters Mas-
sLynx Software (Waters). Unknown metabolites without stan-
dard were tentatively identified by their exact mass, relative
retention time, and previous publications (19).
Histologic analyses of colon crypts
We measured the length of five colon crypts per animal and
counted the number of cells in each measured crypt in blinded
manner (Supplementary Table S2). Hematoxylin and eosin
(H&E)–stained colon tissue sections were visualized by cellSens
Dimensions camera (Olympus) mounted on BX63 microscope
(Olympus). All measurements were performed using Aperio
ImageScope v12.1.0.5029 (Aperio Technologies Inc.). Prolifer-
ation index (Ki67 index) was studied by immunohistochem-
istry. Colon tissue sections were deparaffinized and antigen
retrieved with hot citrate buffer, pH 6. Endogenous peroxidase
was blocked with H2O2 treatment. Tissue sections were incu-
bated overnight with Ki67 antibody (1:1,000, ab15580;
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Abcam) and detected with anti-rabbit polymer (Biocare) and
DAB enzymatic system. Slides were scanned with Pannoramic
250 Flash II (3D Histech); visualization and analysis were done
in CaseViever (3D Histech). We analyzed 5 crypts per animal
(Supplementary Table S2) and calculated a proliferation index
dividing number of Ki67-positive cells with the number of total
cells within a crypt.
RNA expression studies
Reverse transcription of mRNA (500 ng) was done with Super-
script III (Life Technologies) from individual mice according
to the manufacturer's instructions. Quantitative RT-qPCR of
genes involved in regulation of BA sensing and metabolism, Fxr
(F: 5'-GCAGAGCGTACTCCTCCTGA-3' and R: 5'-GACATGCA-
GACCTGTTGGAA-3') and Shp (F: 5'-AAGGGCTTGCTGGACA-
GTTA-3' and R: 5'-TCTCTTCTTCCGCCCTATCA-3'), was studied
using SyberGreen chemistry (Thermo Fisher). Individual mice
samples (12 and 18 months) were assayed in triplicates for the
target genes using the following cycling parameters: 1 cycle of
95C for 10 minutes, 40 cycles of 95C for 15 seconds, and 60C
for 1 minute. b-Actin was used as an endogenous reference gene
(F: 5'-CTAAGGCCAACCGTGAAAAG-3' and R: 5'-ACCAGAGG-
CATACAGGGACA-3'). Thermal cycling and fluorescence data
acquisition were performed with the CFX384 Real Time System
(Bio-Rad), and Cq values were obtained using the CFX manager
Software (Bio-Rad). ThemRNA expression changeswere analyzed
using the comparative Ct (DDCt) method, which presents the data
as fold changes in gene expression normalized to the endogenous
reference gene and compared with the expressions in the control
group (12-month AIN).
Statistical analysis
The significance of changes detected inmouseweight, length of
colon crypts, number of cells, proliferation index, and BA con-
centrations was analyzed with the Mann–Whitney U test (20).
The mean and median permutation tests (21) were used to
analyze the expression data from Western blot and RT-qPCR
studies. Pearson correlation was used to analyze expressions
obtained from 2D-DIGE, LC-MS, and Western blot studies for
selected proteins.
Neoplasias and tumors in general follow negative binomial
distribution (22), which was used to analyze our data set. Calcu-
lations were performed in R version 3.2.0. The threshold for
significance was P  0.05.
The expression changes in 2D-DIGE analysis were detected
using the DeCyder 2D version 7.0 (GE Healthcare), and the
significance in expression differences between the mouse groups
was tested with the Student t test with significance threshold
P  0.01. We compared WD groups with their control groups
(AIN) in order to detect diet effect at different time points. For
combined effect of diet and aging, we compared diet groups
from different time points. Principal component analysis (PCA)
of normalized protein abundances from DeCyder 2D was per-
formed in R version 3.2.0.
For LC-MS proteomic analysis, we utilized the between-
subject ANOVA design scheme of TransOmics software.
The thresholds to accept proteins based on differential inten-
sities between treatment and control groups were absolute
fold-change  2 computed from averaged and normalized
protein intensities, and P value  0.05 for ANOVA in all
comparisons.
Network analysis
The lists of up/downregulated protein changes from 2D-DIGE
and LC-MS analyses were analyzed with Ingenuity Pathway Anal-
ysis (IPA; Qiagen). We used core analysis with following settings:
ingenuity knowledge base (genes and endogenous chemicals)
with direct and indirect relationships, for network interaction:
include endogenous chemicals, 35 molecules per network, and
25 networks per analysis. All data sources were used with confi-
dence: experimentally observed and highly predicted.We selected
data obtained in all species with relaxed filter and excluded data
on mutant variants. Analyses were exported, and heat maps for
upstream regulators, diseases, and functions and classical path-
ways were created in R package NMF using significant z-scores
calculated in IPA.
Results
Western diet increases weight and induces neoplastic
changes in colon
Mice fed with WD showed a trend of increased weight gain
(Supplementary Fig. S1A). Male mice showed a significant (P ¼
0.036) difference in average weights between 12-month AIN
(41.41 g) and 12-month WD (46.50 g) groups, whereas in
females, the weight difference was smaller, 30.10 g and 32.90 g
in 12-month AIN and 12-month WD groups, respectively. At
18 months of age, the average weights of males fed with WD and
AIN were 53.91 g and 42.93 g (P¼ 0.019) and of females 38.10 g
and 36.55 g, respectively. Interestingly, mice fed with AIN con-
tinued to gain weight until 21 months of age, whereas WD-fed
mice started to lose their weights after 18 months most probably
caused by deterioration of wellbeing in the WD groups.
Altogether 6 adenocarcinomas, 1 adenoma, and 13 hyper-
plastic foci had developed during the diet experiment, and 16 of
them inWD-fedmice (Supplementary Table S2).We built a linear
regression model to study the number of tumors in relation to
different diets (AIN or WD) and aging (12, 18, and 21 months).
Aging and diet had significant effect on the number of tumors.
Coefficients for aging andWDwere 1.91, P¼ 0.012 and 1.41, P¼
0.012, respectively. WD on its own increased the likelihood of
developing tumors 4 times and aging from 12 to 21 months 6.75
times. Our model allows us to conclude that at 18months of age,
every thirdmouse fed withWD, and at 21month of age, eachWD
fed mouse would develop at least one macroscopic tumor (lower
limit: 0.58, upper limit: 1.87; Supplementary Fig. S1B).
Proliferation, apoptosis, and BA transport networks are
affected by Western diet
Increased number of tumors in aging mice is a result of
many accumulated alterations occurring in colon epithelium
during the feeding experiment. Since proteomes of mice at
21 months did not differ significantly from proteomes of mice
at 18 months within the same diet groups (Fig. 1A), we focused
on differences in proteomes detected at 12 and 18 months to
address changes that may precede and induce tumors in WD
mice. To assess the changes in colon mucosa proteome during
the feeding experiment, we isolated altogether 77 proximal
colon epithelia samples, operated from the Western and con-
trol (AIN) diet groups at different time points (N ¼ 10–12 mice
per data point, Supplementary Table S2). Protein lysates of
the colon epithelia were analyzed with 2D DIGE (Supplemen-
tary Table S2). Altogether, 1,974 proteins were detected, and
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Figure 1.
Systems biology (networks, upstream activators, biological functions, and canonical pathways) analysis of proteomic changes. A, PCA of all mice in diet
experiment. Arrows, shift of groups fed with AIN and WD from the mice at experiment start point. PCA of all identified proteins by 2D-DIGE shows
proteins that contribute to difference between experimental groups. B, IPA of proteins identified by 2D-DIGE in association with WD revealed activation of
genes involved in proliferation (green) and inactivation of genes involved in apoptosis (red) in 12-month WD and 18-month WD. C, Network analysis of
proteins identified by 2D-DIGE strongly demonstrates activation of PPARs and INSR and inactivation of ACOX1 and MAP4K4 networks. D, IPA of
proteins detected by LC-MS demonstrates activation of proliferation regulators (light green), especially when combining the effect of WD and aging; the
same analysis revealed strong inactivation of NR1H4 (FXR) and BAs (dark green). E, Biological functions and diseases based on proteins detected by LC-MS
indicate activation of proliferation (green), tumorigenesis (yellow), and deregulation of apoptosis (red) in 12-month WDmice. F, Canonical pathways based on
proteins detected by LC-MS supported previous analysis and additionally pointed to active oxidative stress via ROS, metabolic reprogramming, and
inflammatory effects of WD consumption.
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approximately 10% of those showed significant changes
between diet groups. We used peptide mass fingerprinting
(MALDI-TOF TOF) to identify 96 proteins (Supplementary
Table S3), of which 48, 35, and 28 unique proteins showed
significant difference in expression when comparing mice fed
with AIN and WD at 12, 18, and 21 months of age, respectively
(Supplementary Table S4A–S4E). Using these data, the PCA
showed that WD-fed mice diverge from AIN-fed mice, and
especially they differ from mice at experimental start point
(6 weeks) before mouse groups had diet differences. Principal
component (PC)1 mainly associated with diet and described
up to 26% variability between individuals, whereas PC2
described additional 11% of variability and associated mainly
with age. Moreover, we utilized PCA to determine proteins
with highest variability between different experimental groups.
Here, we identified catalase (CAT), cytochrome b-c1 complex
subunit 1, mitochondrial (UQCRC1), fatty acid binding
protein 6 (FABP6), gelsolin (GSN), 3'-phosphoadenosine 5'-
phosphosulfate synthase 2 (PAPSS2), sulfotransferase family,
cytosolic 1A, phenol-preferring, member 1 (SULT1A1), sulfo-
transferase family, cytosolic 1C, member 2 (SULT1C2), and
transgelin (TAGLN; Fig. 1A).
We further used IPA tool for systems biology approach to
identify upstream activators and biological functions enriched
in our dataset. IPA analysis revealed peroxisome proliferator–
activated receptor (PPAR) a, g , and d, and insulin receptor as the
most prominently activated networks and inactivation of acyl-
CoA oxidase 1, palmitoyl (ACOX1), mitogen-activated protein
kinase kinase kinase kinase 4 (MAP4K4), and TNF networks, all
pointing to increased proliferation, deregulation of apoptosis,
and cell death in colon mucosa exposed to WD (Fig. 1B and C).
Highly enriched biological functions for PPAR a, g , and d were
malignant solid tumors (23 proteins, P ¼ 5.44e–5), abdominal
cancer (19 proteins, P ¼ 8.33e–4), epithelial cancer (19 pro-
teins, P ¼ 9.11e–4), breast or colorectal cancer (15 proteins, P ¼
1.74e–4) as well as indicated expected malfunctions in fatty acid
metabolism (Supplementary Table S5A). Top biological func-
tions associated with ACOX1, insulin receptor (INSR), and
MAP4K4 networks were malignant solid tumors (22 proteins,
P ¼ 8.84e–6) and tumorigenesis of tissue (19 proteins, P ¼
1.84e–4; Supplementary Table S4B). Both large networks,
PPARs and ACOX1-INSR-MAP4K4, had in common biological
function of inflammation of organ, respectively (Supplementary
Table S5A and S5B).
We validated our 2D-DIGE findings by LC-MS (Supplementary
Table S6) to rule out biased detection due to inherent limitations
of proteomic methods (23). A proportion of approximately 68%
of proteins identified by 2D-DIGEwere successfully detected with
LC-MS (Supplementary Fig. S2), indicating reliability of the
obtained results. Proteomic data analysis with LC-MS provided
additional protein expression changes. IPA analysis confirmed the
findings of the most significantly altered networks. Cross-com-
parison analysis of LC-MSproteomic data sets between age groups
of 12 and 18 months showed inactivation of FXR (NR1H4) and
confirmedpreviously found changes in PPARs andACOX1. IPAof
biological functions indicated strong inactivation of apoptosis at
12 months in mice fed with WD, together with activation of
tumorigenesis and proliferation. In addition, pathway analysis
pinpointed to divergent behavior of the same pathways at differ-
ent time points favoring proliferation, tumorigenesis, and
increased concentration of ROS (Fig. 1D–F).
Western diet increases cell proliferation in colon crypts
To confirm the results of network and functional analyses of
proteomic data that suggested increased proliferation together
with decreased apoptosis, we measured depth and counted cell
number of colon crypts (Fig. 2A and B). Crypts of mice fed with
WD were 24 mm longer than crypts of control mice at 12
months of age (P ¼ 3.15e–9) and 24 mm longer at 18 months
of age (P ¼ 1.32e–8), respectively. Difference in depth of crypts
between diet groups at 21 months was not significant. Contrary
to WD mice, crypts of AIN mice expressed continuous growth;
15 mm both between 12 and 18 months (P ¼ 9.05e–5) and
between 18 and 21 months (P ¼ 5.84e–05). We observed an
increase in the number of cells within crypts of WD mice
(Supplementary Fig. S3A) with the highest number of cells in
the 12-month WD group. Significantly increased depth of the
crypts, higher number of colonocytes, and IPA results in WD
mice encouraged us to investigate the effects of WD on the
proliferation zone of colon crypts (Fig. 2C and D). Proliferation
index, defined as a ratio between Ki67-positive cells and total
cells within the crypt, was 40% higher in crypts of 12-month
WD mice compared with 12-month AIN mice (P ¼ 3.228e–6).
Control AIN diet did not cause any significant change in
proliferation between different time points, indicating that
significant increase in depth of crypts observed between 12-
month AIN mice and 18-month AIN mice was mainly due to
increased cell size and not due to increased cell number (Sup-
plementary Fig. S3B).
WD-challenged colon mucosa reduces BA reabsorption and
decreases activity of FXR
Data from our proteomic analysis suggested that WD leads
to disruption of lipid metabolism and detoxification of BAs
caused by inactivation of BA sensing and transport (Fig. 1A–
D). FABP6 transports BAs into nucleus where BAs activate
FXR, subsequently regulating expression of genes involved in
BA transport (Asbt, Fabp6, Osta, and Ostb), and an epigenetic
modifier (Shp). FABP6, an intracellular BA transporter in
intestinal epithelial cells, showed the most significant change
in expression between different experimental groups in
2D-DIGE (Fig. 3A). We validated the WD-induced reduction
of FABP6 protein level with LC-MS and Western blot analyses,
and found that the three independent methods showed
high correlation (Pearson's coefficient  0.95, P < 0.05; Sup-
plementary Fig. S4A and S4B). Remarkable WD-induced re-
duction of FABP6 level was observed at 12 months (–4.52,
P ¼ 1.81e–7).
With LC-MS, we also detected a significant expression reduc-
tion of organic solute transporter b subunit (OSTb), known as
solute carrier family 51, beta subunit (SLC51B), which is
exclusively expressed within the basal membrane of colon
epithelium and responsible for transport of BAs into extracel-
lular space. OSTb showed similar expression pattern as FABP6,
with significant reduction in expression at 12 months of age
(–2.16, P ¼ 0.018; Fig. 3B).
ASBT, known as solute carrier family 10member 2 (SLC10A2),
is themain BA importer located on the apical membrane of colon
cells. Because we were not able to detect this protein in either
2D-DIGE or LC-MS, we studied the expression of this protein by
Western blot analysis and found that ASBT was indeed decreased
(–1.57, P ¼ 0.018) in 12-month WD mice when compared with
mice on control diet (Fig. 3C).
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Systems biology analysis suggested inactivation of FXR
(Fig. 1D), and reduced expressions of FABP6 and OSTb
strongly supported inactivation of FXR, main nuclear receptor
for BAs, either (i) by reduced expression or (ii) by reduced
concentration of BA in the tissue. In order to confirm the
inactivation of FXR, we analyzed FXR expression by qPCR and
Western blot. No significant differences were observed in the
Fxr gene expression or protein abundance when comparing
diet groups at 12 months (Fig. 3D; Supplementary Fig. S4C).
Although with increased age, FXR expression was upregulated
in AIN group (Western blot: 1.4, P ¼ 0.004; qPCR: 1.65, P ¼
0.033), the gene and protein expressions of FXR were
decreased in 18-month WD mice in comparison with 18-
month AIN mice (Western blot: –1.35, P ¼ 0.003, qPCR:
Figure 2.
Analysis of colon crypt depth and proliferation index. A, Representative images of H&E-stained colon crypts in different experimental groups show significant
increase of depth of colon crypts in mice fed with WD. B, Significant increase of crypt depth in 12-month WD and 18-month WD when compared with
control groups. C, Representative images of Ki67 proliferation marker show extended proliferation zone in colon crypts of 12-month WD mice. D,
Quantitation of proliferation index. Proliferation zone in colon crypts of 12-month WD mice is significantly extended when compared with controls and with
18-month WD groups. N ¼ 5 crypts/each mouse;  , P < 0.0001.
Figure 3.
Changes in BA transport pathway. A, Abundance of FABP6 measured with 2D-DIGE shows remarkable changes between different experimental groups.
B, Significant reduction of OSTb abundance in 12-month WD mice and increase in 18-month WD mice measured with LC-MS. C, Western blot of ASBT
shows significantly lower ASBT abundance in 12-month WD. D, Protein abundance of FXR measured with Western blot. Western blots were performed in
three independent assays. Error bars, SEM.  , P < 0.05;  , P < 0.01;  , P < 0.001; and  , P < 0.0001.
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–1.79, P ¼ 0.006). Moreover, Shp, another FXR target protein,
showed strongly decreased expression in WD mice when com-
pared with 12-month AIN and 18-month AIN mice (–3.34,
P ¼ 0.031 and –3.15, P ¼ 0.019), respectively (Supplementary
Fig. S4D).
No differences in FXR expression were detected at 12
months. We hypothesized that differences in intracellular BA
pools could affect FXR activity and mediate target gene
transcription; thus, we conducted UPLC-Q-TOF-MS analysis
of BAs in colon tissue and feces collected from colon lumen.
Interestingly, although concentration of BAs was increased
in the luminal feces of 12-month WD mice, indicating ele-
vated BA excretion (Fig. 4A), the intracellular concentra-
tions of several BAs, DCA, and LCA in particular were
significantly reduced in 12-month WD (Fig. 4B), suggesting
decreased transport. Concentration of intracellular DCA
increased, and the fecal concentration of BAs, mainly DCA
and CDCA, decreased over time in mice fed with WD
(12-month WD vs. 18-month WD; Fig. 4C and D). No dif-
ferences were observed in intracellular BA concentra-
tions when comparing 18-month WD with 18-month AIN
(Supplementary Fig. S5A). Aging on control diet did not
change concentration of BAs in colonocytes (12-month AIN
vs. 18-month AIN; Supplementary Fig. S5B). Only luminal
tauro-muricholic acids (TMC) were elevated in 18-month WD
mice when compared with 18-month AIN; however, aging
on control diet reduced concentration of TMCs (Supplemen-
tary Fig. S5C and S5D). Relevance of concentration of DCA
inside the colon tissue was emphasized in a linear regression
analysis, which showed a strong (P ¼ 0.009587) association
between DCA concentration and abundance of FABP6 in
mice fed with WD (Fig. 4E).
Discussion
WD significantly increased the number of tumors in mouse
colon supporting observations from previous studies (5, 24). Our
main finding is that WD increases cell proliferation and tumor-
igenesis in colon in association with severe deregulation of
intracellular BA homeostasis. Aging increased likelihood of devel-
oping tumor, fortifying already established connection between
cancer, aging, and lifestyle (25).
We also detected an increased colon crypt depth and cell
proliferation in WD-fed mice supporting a recently published
result of increased crypt depth caused by HFD (26), which
suggests that HFD enhances stemness and tumorigenicity of
intestinal progenitors via activation of PPAR d. We demon-
strate that WD results in higher abundance of proteins regu-
lated by PPARs (Fig. 1C–E). Although Beyaz and colleagues
focused on changes in intestinal progenitor cells caused by
HFD (60% fat content) and we studied the effects of WD (40%
fat content) in normal colon mucosa cells, an unsupervised
clustering and a heatmap of our 2D-DIGE findings and their
RNA-Seq data (GEO: GSE67324) showed a remarkable corre-
lation between the results (Supplementary Fig. S6).
By using 2D-DIGE and MALDI-TOF/TOF, we identified 96
proteins (Supplementary Table S4A–S4E), which successfully
defined experimental groups in PCA segregating WD-fed mice
from AIN-fed and 6-week-old mice. PCA analysis discriminated
proteins (CAT, FABP6, GSN, PAPSS2, SULT1A1, SULT1C2,
TAGLN, and UQCRC1) that showed the most significant dif-
ferences between experimental groups (Fig. 1A). The increased
expression of CAT (27) and the decreased expression of
UQCRC1 indicate that WD induces oxidative stress and mito-
chondrial dysfunction (4, 6, 28). The decreased expression of
Figure 4.
Metabolomic analysis of BAs in colon tissue and feces from colon lumen. Volcano plots of different
BAs (fatty acids, gray letters). Comparison between 12-month WD and 12-month AIN groups in
content of colon lumen (A) and colon tissue (B). Comparison between 12-month WD and 18-month
WD groups in content of colon lumen (C) and colon tissue (D). DCA, LCA, and total BAs are
significantly reduced in colon epithelia of 12-month WD mice, whereas total BAs, DCA, and LCA
concentrations are increased in colon lumen. Prolonged feeding of WD (12 to 18 months) increases
DCA in colon tissue. Blue dots show significantly reduced and red dots show significantly increased
concentrations of BAs and fatty acids, respectively. Significance threshold P < 0.05 is indicated with
red horizontal line. Concentration is described on the x-axis as log2 value. E, Linear model shows
strong dependence of FABP6 abundance on concentration of DCA inside the tissue only in mice fed
with WD (pink dots, 12-month WD; red dots, 18-month WD mice).
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transformation and shape-changing sensitive actin cross-link-
ing/gelling protein, transgelin (TAGLN), has been previously
detected in primary colorectal cancer tumors, and reduction of
TAGLN has shown to induce proliferation in colon cancer cell
lines (29). Similarly, in our study, colon crypts of 12-month
WD mice showed increased proliferation. Moreover, PAPSS2
and SULT1A1 are essential in the detoxification of BAs and
necessary for avoidance of pathologic conditions such as colon
cancer (30). Downregulation of GSN has been observed in
many transformed cell lines and tumor tissues (breast, colon,
ovaries, prostate, and bladder; ref. 31).
The intracellular BA transporter, FABP6, showed the most
significant difference in expression between experimental
groups and expressed remarkably lower abundance in mice fed
with WD. FABP6 is mainly expressed in the distal portion of the
small intestine and in proximal colon, has a high affinity for
binding BAs, and is essential for their enterohepatic circulation
(32). Expression of Fabp6 is directly induced in a BA-dependent
manner by FXR, which is a key regulator of BA homeostasis (33).
FABP6 is known to functionally associate with FXR and ASBT in
the nucleus and on the membrane, respectively, and to stimulate
FXR activity through a mutual interaction augmented by BA
uptake (34). Lower abundance of FABP6 indicated that colon
tissue of mice fed with WD might have hampered intestinal
apical-basal BA transport as seen in Fabp6/ mice (35). Systems
biology analysis of proteomics data suggested activation of
PPARs and inactivation of FXR (NR1H4) networks, indicating
disruption of lipid metabolism as well as BA sensing and
transport. Moreover, ASBT and OSTb were downregulated in
12-month WD mice, further suggesting inactive BA transport.
Most BAs are efficiently absorbed into the intestinal cells by
ASBT, transported in cytosol by FABP6, and exported across the
basolateral membrane into the portal circulation by the hetero-
dimeric transporter OSTa/OSTb (Fig. 5A; refs. 33, 36).
The consistent downregulation of BA transporters in
12-month WD mice strongly supported two alternative con-
ditions: (i) lower abundance of FXR, which is a common
regulator of BA-related genes (Fabp6, Ostb, Shp; refs. 33, 36–
38) or (ii) reduced FXR activity due to a lower concentration of
BAs. The latter possibility was predicted with IPA (39, 40).
Interestingly, no significant differences were observed in FXR
expression between diet groups at 12 months. Consistent with
reduced expression of transporters, LC-MS analysis of BAs
revealed a significant decrease in intracellular concentrations
of DCA and LCA in the colon epithelium. In contrast, con-
centrations of fecal BAs were increased in 12-month WD mice
reflecting elevated synthesis/excretion and supporting previ-
ous studies that demonstrate increased fecal BAs among indi-
viduals with high dietary fat intake (7). Furthermore, our
linear model showed that the FABP6 abundance is dependent
on the intracellular DCA concentration in mice fed with WD.
Taken together, the results strongly suggest downregulation of
Figure 5.
Proposed model: Western diet impairs BA transport in colon and reduces FXR activity. A, Steady state in colonocyte. BAs (green circles) are transported
into the colonocyte by ASBT and distributed by FABP6 to FXR and to OSTa/OSTb transporter on the basal membrane for active reuptake. BAs act
as activating ligands of FXR, which induces expression of its targets Fabp6, Shp, Osta/Ostb. B, Western diet induces disruption of BA transport in
colonocytes after 12 months of feeding. Concentration of DCA and LCA increases in the colon lumen with consumption of high fat, but reduces
inside the tissue. BAs are imported predominantly by ASBT, in which downregulation may be caused by increased levels of cholesterol and reduced
vitamin D in WD, triggering inactivation of SREBP2 or VDR, respectively. ASBT, FABP6, and OSTb have reduced abundance, indicating impaired BA
transport. As an effect, activity of FXR is reduced, which causes decreased expression of its target genes such as Fabp6, Osta/Ostb, and Shp. C, Prolonged
feeding with WD (12 to 18 months) increases DCA concentration within the tissue, which increases FXR activity, resulting in many upregulated FXR target
genes. At the same time, luminal concentration of DCA and CA reduces. Blue arrows and letters, observed lower abundance or expression; red arrows and
letters, higher abundance or expression. Black letters, unchanged expression. Interestingly, mice with normal BA transport, fed with control diet, developed
significantly fewer colonic neoplasias, whereas mice fed with WD showed attenuated BA transport at 12 months and later in life (18 and 21 months)
developed substantially more colonic neoplasias and tumors.
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FABP6 and other FXR targets, Shp and OSTb, via decreased
activity of FXR.
Import rate of BAs into the colonocytes is determined
by abundance of ASBT, which transcription is regulated by
multiple pathways. Here, downregulated ASBT expression,
reduced BA uptake, and increased fecal BAs reassemble obser-
vations detected by a study that demonstrates downregulation
of ASBT by increased cholesterol via SREBP2 (41). Interestingly,
Western diet used in our study was modified by substituting
plant-based fat with anhydrous milk fat (Supplementary Table
S1), which contains increased amount of cholesterol. Further-
more, inactivation of SREBP2 was identified in systems biology
analysis of LC-MS proteomics (Supplementary Fig. S7). In
addition, increased cytokines and reduced activity of vitamin
D receptor (VDR) have been shown to reduce transcription of
Asbt (42, 43) in line with our IPA network analysis that pointed
to increased inflammation, previously attributed to WD (4),
and decreased content of vitamin D in Western diet (Supple-
mentary Table S1). Taken together, our data strongly suggest
that WD most likely modulates ASBT abundance via several
mechanisms: increased cholesterol and SREBP2, reduced activ-
ity of VDR, and increased cytokines due to inflammation (Fig.
5B and C).
Reduced amount of intracellular secondary BAs,DCA especially,
downregulates transcriptional activity of FXR. Targeted disruption
of Fxr gene inmice (Fxr/) results in defective feedback inhibition
of hepatic BA synthesis and elevated BA excretion in association
with loss of FABP6 in the intestine (44), but mice do not develop
intestinal tumors. However, FXR deficiency increases intestinal cell
proliferation, inflammation, and promotes carcinogenesis in
murine models of intestinal cancers (ApcMin mice and azoxy-
methane-treated mice; ref. 11). Another study shows that not
merely the elevation of circulating BA per se but the absence of
FXR in the intestinal epithelium increases susceptibility to intes-
tinal tumorigenesis (12). Interestingly, we show that increased
proliferation detected in 12-month WD mice coincides with
decreased FXR activity, rather than expression (Fig. 5B and C).
It is worth noticing that patients with inflammatory bowel
disorder have repressed FXR and SHP in the ileum and colon, and
activation of FXR has been shown to reduce intestinal inflamma-
tion (45, 46). Our findings add-up to already growing evidence
that BAs and FXR are important factors in colon inflammation
(47) and colorectal cancer etiology, suggesting that intracellular
BA concentration may have a greater effect than previously
anticipated.
Studies on colon cancer cell lines have shown contradictory
effects of BAs on MUC2 expression depending on length of the
treatment and concentration of BAs (48) urging in vivo studies
to clarify effects of BAs on MUC2, an important tumor-sup-
pressor gene in colorectal cancer (49). Here, we detected an
increased expression of MUC2 in 12-month WD, suggesting
normal homeostatic response to WD challenge in order to
protect the epithelium. However, longer feeding decreased its
expression (Supplementary Fig. S8), suggesting an increased
cancer predisposition (50).
In summary, we show that WD increases tumorigenesis by
swaying BA homeostasis in colon. Fecal BA concentrations
were elevated in WD-fed mice, whereas in corresponding
colon tissue, concentrations decreased in association with
defective transport, as demonstrated by reduced expressions
of BA transporters, FABP6, OSTb, and ASBT. Moreover,
decreased intracellular concentrations of secondary BAs, DCA,
and LCA indicate reduced activity of FXR. Because AIN mice
with active FXR and BA transport develop significantly fewer
neoplastic lesions than WD-fed mice, we suggest that active BA
transport is necessary for prevention of tumorigenesis. Over-
all, the results support previously proposed suggestion (51)
that FXR agonists could be useful for preventive colorectal
cancer treatment in Western populations.
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